Intratracheal surfactant replacement therapy in neonatal respiratory distress syndrome has been established in clinical trials. The observation that lung function in ventilated preterm lambs can be improved by treatment with aerosolized surfactant is a promising recent advance (Lewis, JF et al., J. Appl. Physiol. 70: 869-876, 1991). Although more than 95 % of the aerosolized surfactant was lost in the nebulizer, the dose deposited in the lungs (2 mg/kg) seemed as effective as a 25-fold larger dose of surfactant administered by conventional instillation...
Neonatologists prefer non-invasive ventilation methods for pre-term neonates, who often require surf...
Exogenous surfactant therapy has been recognised as an approach to alleviating the surfactant-defici...
In the last 4 decades, advances in neonatology have led to a significant increase in the survival of...
Currently, the administration of surfactant to preterm infants with respiratory distress syndrome (R...
Background:Aerosolization of exogenous surfactant remains a challenge. This study is aimed to evalua...
BACKGROUND: Surfactant replacement therapy is a recognized treatment for respiratory distress syndro...
AbstractSurfactant therapy is an established part of routine clinical management of babies with resp...
A new technique was proposed to administer surfactant to spontaneous breathing preterm infants by pl...
BACKGROUND: Surfactant replacement therapy is the gold standard treatment of neonatal respiratory di...
Exogenous surfactant has been the primary life-saving therapy for respiratory distress syndrome (RDS...
Although superiority of synthetic surfactant over animal-driven surfactant has been known, there is ...
BACKGROUND: Respiratory distress syndrome in preterm babies is caused by a pulmonary surfactant defi...
Although superiority of synthetic surfactant over animal-driven surfactant has been known, there is ...
Background: Respiratory distress syndrome in preterm babies is caused by a pulmonary surfactant defi...
Neonatologists prefer non-invasive ventilation methods for pre-term neonates, who often require surf...
Exogenous surfactant therapy has been recognised as an approach to alleviating the surfactant-defici...
In the last 4 decades, advances in neonatology have led to a significant increase in the survival of...
Currently, the administration of surfactant to preterm infants with respiratory distress syndrome (R...
Background:Aerosolization of exogenous surfactant remains a challenge. This study is aimed to evalua...
BACKGROUND: Surfactant replacement therapy is a recognized treatment for respiratory distress syndro...
AbstractSurfactant therapy is an established part of routine clinical management of babies with resp...
A new technique was proposed to administer surfactant to spontaneous breathing preterm infants by pl...
BACKGROUND: Surfactant replacement therapy is the gold standard treatment of neonatal respiratory di...
Exogenous surfactant has been the primary life-saving therapy for respiratory distress syndrome (RDS...
Although superiority of synthetic surfactant over animal-driven surfactant has been known, there is ...
BACKGROUND: Respiratory distress syndrome in preterm babies is caused by a pulmonary surfactant defi...
Although superiority of synthetic surfactant over animal-driven surfactant has been known, there is ...
Background: Respiratory distress syndrome in preterm babies is caused by a pulmonary surfactant defi...
Neonatologists prefer non-invasive ventilation methods for pre-term neonates, who often require surf...
Exogenous surfactant therapy has been recognised as an approach to alleviating the surfactant-defici...
In the last 4 decades, advances in neonatology have led to a significant increase in the survival of...